Altria Group Inc

Altria shares recovered to $71.94, up 0.74%, as the June 15 ex-dividend date approaches. The stock offers a 5.89% yield and trades near the average analyst target of $71.75. All eyes are on July 30 Q2 earnings.

Altria surged 2.25% to $72.19 on Friday, defying a broad market selloff, as investors assessed Senate scrutiny of FDA vape policy and a June 15 dividend cutoff.

Philip Morris shares dropped 6.14% in a holiday-shortened week, closing at $177.38, as the market awaits CEO Jacek Olczak's webcast and FDA policy changes on nicotine products.

Altria shares ended Friday at $73.90, near a 52-week high, following its smokeless tobacco unit's plan to move production from Nashville to Kentucky by early 2028.

Altria shares climbed 7.3% over the week, closing at $73.09, as the company named a new CEO and declared a $1.06 quarterly dividend, offering a 5.8% yield.

Altria shares fell 1.3% to $68.12, extending a five-session losing streak despite a Q1 earnings beat. Rising competition in the nicotine pouch market and declining cigarette volumes weigh on the stock ahead of its May 14 annual meeting.

Altria shares rose 7% after Q1 earnings beat estimates, driven by price hikes that offset a 2.4% drop in cigarette shipments.

Altria Group (MO) reports Q1 earnings April 30 as CEO Billy Gifford prepares to retire May 14. Analysts expect $1.25 EPS on $4.58B revenue. The company faces declining cigarette volumes and a critical test for its nicotine pouch strategy.

British American Tobacco is being sued in London by over 100 shareholders who allege the company did not properly disclose U.S. sanctions violations related to its North Korea operations. The legal action follows BAT's $635.2 million settlement with U.S. authorities in 2023.

Philip Morris shares climbed 1.4% to $188.95, setting a new 52-week high. The gain came despite India's health ministry refusing to relax its ban on heated tobacco, blocking the IQOS launch.